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Abstract
Urinary bladder pheochromocytoma is rare. From a case report of unsuspected pheochromocytoma
and literature review, the authors develop a diagnostic and therapeutic algorithm for the management
of this ectopic pheochromocytoma localization.
Introduction
Pheochromocytoma is a neuroendocrine tumour that
usually develops ahead of the chromaffin cells of the
adrenal medulla. The Pheochromocytoma of the urinary
bladder accounts for less than 1% of the pheochromocy-
tomas and less than 0.06% of the bladder tumors [1]. The
usual signs are haematuria, hypertension during micturi-
tion together with generalized symptoms due to raised
catecholamines (headache, blurred vision, heart palpita-
tion, flushing). However, 27% of pheochromocytomas
of the urinary bladder do not feature any hormonal
activity [2].
Following an observation of pheochromocytoma of the
urinary bladder, this paper aims at reminding the clinical,
therapeutic and histological features of this rare tumour.
Case presentation
A 55 year-old Moroccan housewife presented with a 6
months history of haematuria associated with anemia. The
physical and paraclinic examinations were normal, her
blood pressure showed a 120/80 mmhg. Ultrasonography
revealed a 4 cm size heterogeneous mass located in the
bladder dome (Figure 1). Computed tomography of the
abdomen showed a well defined 3.5 cm size tumour
located in the anterior front of the bladder, with a
heterogeneous increase in density after injection of
iodine-containing contrast solution (Figure 2).
Cystoscopy demonstrated a smooth tumour in the wall
of the bladder with normal mucosa and transurethral
resection provided tissue material for histological
examination that suggested a bladder paraganglioma
(Figures 3, 4). Dosage of metanephrine and normeta-
nephrine in 24-hour urine was anomaly free computed
tomography performed one month later showed a greater
thickness of the anterior front of the bladder, with an
increase in density after the injection of iodine-containing
contrast solution (Figure 5). Partial cystectomy was
therefore performed. The postoperative course was
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closed typical findings of pheochromocytoma.
Discussion
Pheochromocytoma develops from the germinal cells of
neural crest, and is usually an adrenal tumor. The
Pheochromocytoma of the bladder was first described by
Zimmermann in 1953 [3], and more than 70 cases have
been spotted since then. The paraganglioma of the bladder
is very rare and represents less than 6% of the whole range
of paragangliomas and less than 1% of the bladder tumors
[4]. The paraganglioma of the bladder is usually a unique
tumor with a submucous development [1]. The average
age of the patients are relatively low, nearby 40 years, with
a range going from 10 to 78 years, with high frequency
during the adolescence (17% of the patients hit were less
than 15) and the thirties. There is no sex predominance in
opposition to the adrenal pheochromocytoma that is
affecting the female gender in bigger proportion [5].
Typical symptoms are sharp headaches, hypertension,
palpitation and sweating. Increased catecholamine release
in association with bladder contraction during micturition
can also provoke faintness immediately after bladder
voiding. Hypertensive crises may be triggered by micturi-
tion, defecation, sexual activity, ejaculation or bladder
instrumentation. These evocative symptoms are observed
in 65% of the cases [4]. Haematuria can suggest the
diagnosis as 65% of the patients were concerned.
Paroxysmal hypertension was reported in 65% of the
Figure 1. Ultrasonography showing a heterogeneous mass
located in the bladder dome.
Figure 2. CT showing tumour located in the anterior front of
the bladder with well defined bounds.
Figure 3. Tumourous proliferation composed of small cells
associated to endocrine visualization. (HES x 10).
Figure 4. Tumourous cells showing a positive
immunostaining for synaptophysin. (HES x 40).
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hypogastric mass with the size of a nutshell. The above
mentioned clinical table recommends the measurement of
catecholamines and catecholamine metabolites (meta-
nephrine and normetanephrine) in plasma and 24-hour
urine samples. Signs of hormonal activity are displayed in
83% of the bladder pheochromocytomas.
In a recent study on patients affected by extra-adrenal
pheochromocytomas, the urinary metanephrine rate was
high in 88% of the cases (greater than 0.9 mg/24 h) [6]. In
71% of the cases, the vanyl-mandelic acid (VMA)
measurement was positive (greater than 6.8 mg/24 h)
and a high concentration of plasmatic catecholamines was
discovered in 88% of the patients. However, our patient
had a normal urinary catecholamines measurement. The
VMA dosage has not been performed as the secreting
activity of the tumor occurs only during the contractile
phase of the detrusor. It can persist only 5 minutes
afterwards, which questions the reliability of the 24 hours
measurement [7,8]. Ultrasonography and computed
tomography (CT) maintain the tissue nature of the
tumor, with an increasing density after iodine contrast
solution injection. These examinations give also the
opportunity to look for concomitant locations, as well as
potential ganglionic or visceral metastasis [4].
The Magnetic Resonance Imaging (MRI) is a very reliable
examination that can also detect other localizations
despite their small size. The characterization of the tissues
is outstanding, especially at the level of the bladder and
the vascular axes; MRI is also more adapted than CT in the
evaluation of the paragangliomas [8]. In order to enhance
the diagnosis and the localization of the paragangliomas, a
new imaging method has been recently developed using
the iodin-131-MIBG scanning [9]. This examination
presents sensitivity of 78% to the adrenal pheochromocy-
toma, and varies in the range from 67% to 89% when it
comes to extra-adrenal localizations.
This examination is more adapted if several localizations
are investigated or for the purpose of detection of bone
metastasis. However, its high cost is a real limitation.
Cystoscopy should be avoided if a bladder pheochromo-
cytoma is suspected, as no prior preparation may have
deadly consequences. Through cystoscopy, pheochromo-
cytomas appear as granulated and lobulated lesions with
or without ulceration. Similar observations were made for
our patient [2,8].
The treatment of the bladder pheochromocytoma is solely
surgical and the patient preparation is an essential step,
covering a preoperative treatment with a- and b-blocking
agents. Surgical resection is the treatment of choice [4].
Due to the multilayer involvement of the bladder wall,
open surgery to perform a partial cystectomy is recom-
mended. In the presence of proven metastasis, radical
cystectomy with pelvic lymphadenectomy is recom-
mended [1]. Radiotherapy and chemotherapy have
limited effectiveness.
A long term follow up with regular biological and clinical
examinations isnecessary, inorderto detect anyrecurrence
or metastasis. From a histological perspective, the usual
criteria of malignancy have no ground, but the appearance
of a metastasis is a sign of malignancy [4].
Even if 170 cases of bladder pheochromocytoma have
been reported so far, only 17 well documented cases are
malignant [10]. The prognosis of the bladder pheochro-
mocytoma remains favorable.
Conclusion
Pheochromocytoma of the bladder is a rare tumor. Its
diagnosis is suspected in the presence of paroxysmal hyper
blood pressure paired with a bladder tumor. The partial or
radical cystectomy remains the treatment of choice in case
of malignancy.
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Figure 5. CT showing a greater thickness of the anterior
front of the bladder increasing its density after the injection
of iodine-containing contrast solution.
Page 3 of 4
(page number not for citation purposes)
Cases Journal 2009, 2:8585 http://casesjournal.com/casesjournal/article/view/8585Competing interest
The authors declare that they have no competing interests.
Author’s contributions
MFT analyzed and interpreted the patient data regarding
the bladder disease. YA and ET have made contributions to
conception and design, and acquisition of data. LC and AB
performed the histological examination of the kidney, and
was a major contributor in writing the manuscript. MJE
has been involved in drafting the manuscript and revising
it critically for important intellectual content. MHF has
given final approval of the version to be published. All
authors read and approved the final manuscript.
References
1. Kappers MH, van den Meiracker AH, Alwani RA, Kats E, Baggen MG:
Paraganglioma of the urinary bladder. Neth J Med 2008,
66:163-165.
2. Naqiyah I, Rohaizak M, Meah FA, Nazri MJ, Sundram M, Amram AR:
Phaeochromocytoma of the urinary bladder. Singapore Med J
2005, 46:344-346.
3. Zimmerman IJ, Biron RE, MacMahan HE: Pheochromocytoma of
the 2 urinary bladder. N Engl J Med 1953, 249:25-26.
4. Attyaoui F, Nouira Y: Le phéochromocytome vésical. Progrès en
Urologie 2000, 10:95-98.
5. Zidi B, Bouzian A, Ben Hamadi F: Le phéochromocytome
extrasurrénalien.bA propos de trois observations et revue
de la littérature. Rev Mid Interne 1995, 16:102-109.
6. Goldfarb DA, Novick AC, Bravo EL, Straffon RA, Montie JE, Kay R:
Experience with extra-adrenal pheochromocytoma. J Urol
1989, 142:931-936.
7. Messerli FH, Finn M, McPhee AA: Pheochromocytoma of the
urinary bladder, systemic hemodynamics and circulating
cathecolamine levels. JAMA 1982, 247:1863-1864.
8. Whalen RK, Althausen AF, Daniels GH: Extra-adrenal pheochro-
mocytoma. J Urol 1992, 147:1-10.
9. Tissaoui K, El Kamel R, Zidi B, Ben Hamadi F, Karray S, Berraies N,
Ben Moussa MA: propos d’une observation de phéochromocy-
tome vésical. Prog Urol 1992, 2:253-257.
10. Michel F, Gattegno B, Sicard JF, Roland J, Thibault P: A propos d’une
observation de phéochromocytome vésical malin Conduite
diagnostique et thérapeutique. Ann Urol 1990, 24:396-399.
Page 4 of 4
(page number not for citation purposes)
Cases Journal 2009, 2:8585 http://casesjournal.com/casesjournal/article/view/8585
Do you have a case to share?
Submit your case report today
￿ Rapid peer review
￿ Fast publication
￿ PubMed indexing
￿ Inclusion in Cases Database
Any patient, any case, can teach us
something
www.casesnetwork.com